pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Amyotrophic Lateral Sclerosis, Acute Myeloid Leukemia, Mastocytosis, Mast cell activation syndrome, Multiple Scleros
PARIS, FR HQ
20 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 6
- Drugs
- 11
- Patents
- 25
AB15003
Phase 3 · small molecule · Mastocytosis
AB15003 for Mastocytosis is a Phase 3 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Internal code AB15003
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AB Science
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Mastocytosis
- Status
- active
- Trials
- 1